Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL)

被引:19
作者
Kondo, S
Kotani, T
Tamura, K
Aratake, Y
Uno, H
Tsubouchi, H
Inoue, S
Niho, Y
Ohtaki, S
机构
[1] MIYAZAKI MED COLL, DEPT LAB MED, MIYAZAKI 88916, JAPAN
[2] MIYAZAKI MED COLL, DIV BLOOD TRANSFUS, MIYAZAKI 88916, JAPAN
[3] MIYAZAKI MED COLL, CENT LAB CLIN INVEST, MIYAZAKI 88916, JAPAN
[4] MIYAZAKI PREFECTURAL HOSP, MIYAZAKI, JAPAN
[5] MIYAZAKI MED COLL, DEPT DERMATOL, MIYAZAKI 88916, JAPAN
[6] KYUSHU UNIV, FAC MED, DEPT INTERNAL MED 1, FUKUOKA 812, JAPAN
关键词
ATLL; CD26; HTLV-I;
D O I
10.1016/0145-2126(95)00159-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association of CD26/dipeptidyl peptidase IV (DPPIV) and human T lymphotropic virus type I (HTLV-I) was studied by two approaches. First, we examined the expression of CD26 in peripheral blood mononuclear cells (PBMC) from the patients with adult T cell leukemia/lymphoma (ATLL), an HTLV-I-related malignancy. The expression of CD26 on the surface of PBMC was decreased in all 20 patients with ATLL compared with those from normal individuals (P<0.01) and the expression of the CD26 gene transcript was not detectable in seven out of eight patients with ATLL. Then we compared the quantity of viral DNA in CD26-negative (CD26-) and CD26-positive (CD26+) cells obtained from 17 HTLV-I healthy carriers by using a polymerase chain reaction method. The CD26- cells had a higher copy number of viral DNA than CD26+ cells. These findings indicate that HTLV-I has in vivo tropism to CD26- cells, suggesting that some phenotypes of ATLL cells reflect the in vivo cellular tropism of HTLV-I. (C) 1996 Published by Elsevier Science Ltd.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 35 条
  • [1] BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073
  • [2] BRODER CC, 1994, SCIENCE, V264, P1156, DOI 10.1126/science.7909959
  • [3] T-CELL ACTIVATION ANTIGEN, CD26, AS A COFACTOR FOR ENTRY OF HIV IN CD4+ CELLS
    CALLEBAUT, C
    KRUST, B
    JACOTOT, E
    HOVANESSIAN, AG
    [J]. SCIENCE, 1993, 262 (5142) : 2045 - 2050
  • [4] DANG NH, 1990, J IMMUNOL, V145, P3963
  • [5] ENSSLE KH, 1990, CLIN EXP IMMUNOL, V79, P409
  • [6] TRIGGERING OF THE LETHAL HIT IN HUMAN CYTOTOXIC LYMPHOCYTES-T - A FUNCTIONAL-ROLE FOR A 103-KDA T-CELL-SPECIFIC ACTIVATION ANTIGEN
    FLEISCHER, B
    SCHENDEL, DJ
    VONSTELDERN, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (07) : 741 - 746
  • [7] CD26 - A SURFACE PROTEASE INVOLVED IN T-CELL ACTIVATION
    FLEISCHER, B
    [J]. IMMUNOLOGY TODAY, 1994, 15 (04): : 180 - 184
  • [8] FOX DA, 1984, J IMMUNOL, V133, P1250
  • [9] C-FOS PROMOTER TRANS-ACTIVATION BY THE TAX1 PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I
    FUJII, M
    SASSONECORSI, P
    VERMA, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) : 8526 - 8530
  • [10] HAFLER DA, 1986, J IMMUNOL, V137, P414